Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2677 |
|
| Actual shortage: | 255 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2413 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (9%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-LISINOPRIL (TYPE P) | 5MG | TABLET | Resolved | 2017-03-14 | 2017-05-10 | 2312 |
| TEVA-LISINOPRIL (TYPE P) | 20MG | TABLET | Resolved | 2019-11-21 | 2020-01-24 | 99444 |
| TEVA-LIOTHYRONINE | 5MCG | TABLET | Resolved | 2021-06-10 | 2021-07-09 | 140684 |
| TEVA-LIOTHYRONINE | 5MCG | TABLET | Resolved | 2021-12-02 | 2022-01-20 | 150400 |
| TEVA-LEVOCARBIDOPA | 25MG 100MG | TABLET | Resolved | 2017-03-14 | 2017-11-07 | 2297 |
| TEVA-LEVOCARBIDOPA | 25MG 100MG | TABLET | Resolved | 2017-04-03 | 2017-11-07 | 5207 |
| TEVA-LEVOCARBIDOPA | 25MG 250MG | TABLET | Resolved | 2017-08-01 | 2018-02-22 | 17896 |
| TEVA-LEVOCARBIDOPA | 25MG 250MG | TABLET | Resolved | 2017-08-21 | 2018-02-22 | 19973 |
| TEVA-LEVOCARBIDOPA | 25MG 100MG | TABLET | Resolved | 2019-09-26 | 2019-10-10 | 94864 |
| TEVA-LEVOCARBIDOPA | 25MG 100MG | TABLET | Actual shortage | 2019-11-28 | 2022-08-18 | 99935 |
| TEVA-LEVOCARBIDOPA | 25MG 100MG | TABLET | Actual shortage | 2019-12-05 | 2022-08-18 | 100299 |
| TEVA-LEVOCARBIDOPA | 25MG 250MG | TABLET | Actual shortage | 2020-02-21 | 2020-03-26 | 106945 |
| TEVA-LEVOCARBIDOPA | 10MG 100MG | TABLET | Actual shortage | 2020-03-26 | 2020-03-26 | 109550 |
| TEVA-LEVETIRACETAM | 500MG | TABLET | Resolved | 2021-02-25 | 2021-04-08 | 134727 |
| TEVA-LEVETIRACETAM | 500MG | TABLET | Resolved | 2022-01-20 | 2022-01-28 | 153132 |
| TEVA-LEVETIRACETAM | 500MG | TABLET | Resolved | 2023-06-08 | 2023-08-18 | 194103 |
| TEVA-LEVETIRACETAM | 750MG | TABLET | Resolved | 2023-06-08 | 2023-10-04 | 194106 |
| TEVA-LEVETIRACETAM | 750MG | TABLET | Resolved | 2023-06-19 | 2023-10-04 | 195484 |
| TEVA-LEVETIRACETAM | 500MG | TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195591 |
| TEVA-LETROZOLE | 2.5MG | TABLET | Resolved | 2017-08-21 | 2017-09-19 | 19968 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT DILTIAZEM CD | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2019-04-11 | 2019-04-11 | 81381 |
| ACT DILTIAZEM CD | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2019-04-11 | 2019-04-11 | 81418 |
| ACT DILTIAZEM CD | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-07-22 | 2021-07-22 | 142915 |
| ACT DILTIAZEM CD | 300MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-07-22 | 2021-07-22 | 142918 |
| ACT DILTIAZEM CD | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-07-22 | 2021-07-22 | 142921 |
| ACT CLOPIDOGREL | Discontinued | 2018-10-19 | 2018-10-19 | 65065 | ||
| ACT CELECOXIB | 100MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123648 |
| ACT CELECOXIB | 200MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123651 |
| ACT CELECOXIB | 200MG | CAPSULE | Discontinued | 2021-02-12 | 2021-02-12 | 133874 |
| ACT CELECOXIB | 100MG | CAPSULE | Discontinued | 2021-02-12 | 2021-02-12 | 133880 |